Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2014, Article ID 952352, 4 pages
http://dx.doi.org/10.1155/2014/952352
Clinical Study

Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy

Ito Hospital, 4-3-6 Jingumae, Shibuya-ku, Tokyo 150-8308, Japan

Received 2 October 2013; Revised 26 November 2013; Accepted 15 December 2013; Published 9 January 2014

Academic Editor: Julie A. Sosa

Copyright © 2014 Ai Yoshihara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Ecker and T. J. Musci, “Treatment of thyroid disease in pregnancy,” Obstetrics and Gynecology Clinics of North America, vol. 24, no. 3, pp. 575–589, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Mestman, “Hyperthyroidism in pregnancy,” Best Practice & Research, vol. 18, no. 2, pp. 267–288, 2004. View at Google Scholar
  3. F. Otsuka, J. Y. Noh, T. Chino et al., “Hepatotoxicity and cutaneous reactions after antithyroid drug administration,” Clinical Endocrinology, vol. 77, no. 2, pp. 310–315, 2012. View at Google Scholar
  4. H. Nakamura, J. Y. Noh, K. Itoh et al., “Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2157–2162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Watanabe, H. Narimatsu, J. Y. Noh et al., “Antithyroid drug-induced hematopoietic damage: A retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 1, pp. E49–E53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Y. Noh, S. Yasuda, S. Sato et al., “Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, pp. 2806–2811, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Yoshihara, J. Noh, T. Yamaguchi et al., “Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation,” Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. 2396–2403, 2012. View at Google Scholar
  8. H. Rosenfeld, A. Ornoy, S. Shechtman, and O. Diav-Citrin, “Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study,” British Journal of Clinical Pharmacology, vol. 68, no. 4, pp. 609–617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. S. Cooper and S. A. Rivkees, “Putting propylthiouracil in perspective,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, pp. 1881–1882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. N. Taylor and B. Vaidya, “Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy,” European Thyroid Journal, vol. 1, no. 3, pp. 176–185, 2012. View at Google Scholar
  11. P. Kontoleon, I. Ilias, D. A. Koutras, D. Kontogiannis, and P. D. Papapetrou, “Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report,” Clinical and Experimental Obstetrics and Gynecology, vol. 29, no. 4, pp. 304–305, 2002. View at Google Scholar · View at Scopus
  12. W. A. Parker, “Propylthiouracil-induced hepatotoxicity,” Clinical Pharmacology, vol. 1, no. 5, pp. 471–474, 1982. View at Google Scholar
  13. P. Taylor, S. Bhatt, R. Gouni, J. Quinlan, and T. Robinson, “A case of propylthiouracil-induced hepatitis during pregnancy,” European Thyroid Journal, vol. 1, no. 1, pp. 41–44, 2012. View at Google Scholar
  14. C. Y. Hayashida, A. J. S. Duarte, A. E. Sato, and E. H. Yamashiro-Kanashiro, “Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil,” Journal of Endocrinological Investigation, vol. 13, no. 11, pp. 937–941, 1990. View at Google Scholar · View at Scopus
  15. L. de Groot, M. Abalovich, E. K. Alexander et al., “Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 8, pp. 2543–2565, 2012. View at Google Scholar
  16. A. Stagnaro-Green, M. Abalovich, E. Alexander et al., “Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum,” Thyroid, vol. 21, no. 10, pp. 1081–1125, 2011. View at Publisher · View at Google Scholar · View at Scopus